Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVXL Anavex Life Sciences Corp.

休市中 12-19 16:00:00 EST

3.67

-0.22

-5.66%

盘后3.73

+0.06+1.63%

19:55 EST

最高4.01	最低3.60	成交量527.99万
今开3.90	昨收3.89	日振幅10.54%
总市值3.28亿	流通市值3.05亿	总股本8,935万
成交额1,976万	换手率6.36%	流通股本8,305万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVXL","market":"US","secType":"STK","nameCN":"Anavex Life Sciences Corp.","latestPrice":3.67,"timestamp":1766178000000,"preClose":3.89,"halted":0,"volume":5279851,"hourTrading":{"tag":"盘后","latestPrice":3.73,"preClose":3.67,"latestTime":"19:55 EST","volume":130196,"amount":477869.0865,"timestamp":1766192102227},"delay":0,"floatShares":83048051,"shares":89348107,"eps":-0.54376,"marketStatus":"休市中","change":-0.22,"latestTime":"12-19 16:00:00 EST","open":3.9,"high":4.01,"low":3.6,"amount":19755562.5202794,"amplitude":0.105398,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.54376,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.89,"preHourTrading":{"tag":"盘前","latestPrice":3.92,"preClose":3.89,"latestTime":"09:03 EST","volume":5760,"amount":22408.626816,"timestamp":1766153024481},"postHourTrading":{"tag":"盘后","latestPrice":3.73,"preClose":3.67,"latestTime":"19:55 EST","volume":130196,"amount":477869.0865,"timestamp":1766192102227},"volumeRatio":1.9119812689522493,"impliedVol":1.3278,"impliedVolPercentile":0.812},"requestUrl":"/m/hq/s/AVXL","defaultTab":"news","newsList":[{"id":"1133705605","title":"Anavex Life Sciences关于Blarcamesine治疗早期阿尔茨海默病的欧盟监管审查最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1133705605","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133705605?lang=zh_cn&edition=full","pubTime":"2025-12-13 05:06","pubTimestamp":1765573571,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences关于Blarcamesine治疗早期阿尔茨海默病的欧盟监管审查最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2588703523","title":"Anavex Life Sciences Corp.盘中异动 大幅拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588703523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588703523?lang=zh_cn&edition=full","pubTime":"2025-12-02 01:52","pubTimestamp":1764611576,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日01时52分，Anavex Life Sciences Corp.股票出现波动，股价急速上涨5.22%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为1.53%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202015256a71d5f89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202015256a71d5f89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1101878650","title":"Anavex Life Sciences Corp：预计以当前现金使用率计算，现金流动性超过3年","url":"https://stock-news.laohu8.com/highlight/detail?id=1101878650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101878650?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:35","pubTimestamp":1764074110,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp：预计以当前现金使用率计算，现金流动性超过3年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1188499538","title":"Anavex Life Sciences公布2025财年第四季度财务业绩并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1188499538","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188499538?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:31","pubTimestamp":1764073883,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences公布了2025财年第四季度的财务结果，并提供了业务更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1104025186","title":"Anavex Life Sciences Corp - Blarcamesine显示良好的安全性，无治疗相关死亡病例","url":"https://stock-news.laohu8.com/highlight/detail?id=1104025186","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104025186?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:33","pubTimestamp":1761737582,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp - Blarcamesine显示良好的安全性，无治疗相关死亡病例","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1173376908","title":"Anavex Life Sciences宣布口服Blarcamesine的持续长期益处，与阿尔茨海默病神经影像倡议(Adni)对照组的下降情况相比","url":"https://stock-news.laohu8.com/highlight/detail?id=1173376908","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173376908?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:32","pubTimestamp":1761737540,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences宣布口服Blarcamesine的持续长期益处，与阿尔茨海默病神经影像倡议(Adni)对照组的下降情况相比","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1120012793","title":"Anavex Life Sciences Corp.：次要分析和探索性分析在多项结果指标中显示积极趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=1120012793","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120012793?lang=zh_cn&edition=full","pubTime":"2025-10-02 19:33","pubTimestamp":1759404795,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp.：次要分析和探索性分析在多项结果指标中显示积极趋势","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1154690609","title":"Anavex Life Sciences Corp.公布Anavex®3-71治疗精神分裂症2期研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1154690609","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154690609?lang=zh_cn&edition=full","pubTime":"2025-10-02 19:31","pubTimestamp":1759404673,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences Corp.宣布其药物Anavex®3-71用于治疗精神分裂症的2期临床研究取得积极的顶线结果。该公司表示，这一研究成果为该药物的进一步开发提供了重要的临床数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1125112762","title":"Anavex Life Sciences宣布发表口服Blarcamesine研究论文，描述来自阿尔茨海默病II期b/III期试验的新型临床精准医学","url":"https://stock-news.laohu8.com/highlight/detail?id=1125112762","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125112762?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:33","pubTimestamp":1759235626,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences宣布发表口服Blarcamesine研究论文，描述来自阿尔茨海默病II期b/III期试验的新型临床精准医学。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2566623620","title":"Anavex Life Sciences Corp.盘中异动 早盘急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566623620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566623620?lang=zh_cn&edition=full","pubTime":"2025-09-09 23:25","pubTimestamp":1757431515,"startTime":"0","endTime":"0","summary":"北京时间2025年09月09日23时25分，Anavex Life Sciences Corp.股票出现波动，股价大幅上涨5.13%。截至发稿，该股报9.83美元/股，成交量37.1427万股，换手率0.43%，振幅3.80%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.12%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909232515a719f29f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909232515a719f29f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"1182130839","title":"Anavex Life Sciences宣布口服布拉卡美辛认知恢复力结果接近正常老化水平，精准医学临床数据来自阿尔茨海默病IIb/III期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1182130839","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182130839?lang=zh_cn&edition=full","pubTime":"2025-09-09 19:31","pubTimestamp":1757417484,"startTime":"0","endTime":"0","summary":"Anavex Life Sciences宣布口服布拉卡美辛认知恢复力结果接近正常老化水平，精准医学临床数据来自阿尔茨海默病IIb/III期试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"1111490528","title":"异动解读 | Anavex生命科学盘中大跌5%，季度亏损超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1111490528","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111490528?lang=zh_cn&edition=full","pubTime":"2025-08-12 22:11","pubTimestamp":1755007882,"startTime":"0","endTime":"0","summary":"生物制药公司Anavex Life Sciences Corp.今日盘中大跌5.02%，主要受到公司最新季度财报不及预期的影响。根据公司公布的截至6月30日的季度业绩报告，Anavex调整后每股亏损16美分，低于分析师预期的14美分亏损。尽管短期内股价承压，但Anavex的长期表现仍然积极。此外，华尔街分析师对Anavex保持乐观态度，目前对该公司股票的平均评级为\"买入\"，12个月目标价中位数为42.00美元，较最近收盘价11.35美元高出约73%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVXL"],"gpt_icon":0},{"id":"2557288598","title":"Anavex Life Sciences Corp.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557288598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557288598?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:35","pubTimestamp":1754588131,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时35分，Anavex Life Sciences Corp.股票出现波动，股价快速上涨5.10%。截至发稿，该股报11.53美元/股，成交量35.8959万股，换手率0.42%，振幅6.07%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.23%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801353294d5fba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080801353294d5fba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2556811182","title":"Anavex Life Sciences Corp.盘中异动 大幅下挫5.31%报10.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556811182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556811182?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:48","pubTimestamp":1754056129,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时48分，Anavex Life Sciences Corp.股票出现波动，股价大幅下跌5.31%。截至发稿，该股报10.70美元/股，成交量13.9058万股，换手率0.16%，振幅3.72%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.26%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801214850a6cdf2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801214850a6cdf2b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2555583971","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大涨5.00%报11.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555583971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555583971?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:45","pubTimestamp":1753969518,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时45分，Anavex Life Sciences Corp.股票出现异动，股价快速拉升5.00%。截至发稿，该股报11.73美元/股，成交量11.773万股，换手率0.14%，振幅4.62%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为2.39%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214518972a5440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731214518972a5440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2554977736","title":"Anavex Life Sciences Corp.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554977736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554977736?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:48","pubTimestamp":1753710526,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时48分，Anavex Life Sciences Corp.股票出现波动，股价快速下挫5.11%。截至发稿，该股报11.51美元/股，成交量25.7354万股，换手率0.30%，振幅5.15%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为0.04%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214846a467e00b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214846a467e00b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2551119562","title":"Anavex Life Sciences Corp.盘中异动 早盘大幅下跌5.14%报10.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119562?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:37","pubTimestamp":1752590222,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时37分，Anavex Life Sciences Corp.股票出现波动，股价快速下挫5.14%。截至发稿，该股报10.89美元/股，成交量29.1357万股，换手率0.34%，振幅4.40%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.16%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223702954398b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223702954398b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2550654096","title":"Anavex Life Sciences Corp.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550654096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550654096?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:41","pubTimestamp":1752079265,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时41分，Anavex Life Sciences Corp.股票出现异动，股价急速拉升5.00%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为1.07%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710004105979fdeb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710004105979fdeb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0},{"id":"2549055581","title":"Anavex Life Sciences Corp.盘中异动 早盘股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549055581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549055581?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:40","pubTimestamp":1751899219,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时40分，Anavex Life Sciences Corp.股票出现异动，股价快速下跌6.12%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体跌幅为0.33%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224019a69b32f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224019a69b32f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVXL"],"gpt_icon":0},{"id":"2548781649","title":"Anavex Life Sciences Corp.盘中异动 股价大涨5.57%报9.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548781649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548781649?lang=zh_cn&edition=full","pubTime":"2025-07-02 23:35","pubTimestamp":1751470533,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时35分，Anavex Life Sciences Corp.股票出现波动，股价大幅拉升5.57%。截至发稿，该股报9.85美元/股，成交量21.5971万股，换手率0.25%，振幅5.29%。Anavex Life Sciences Corp.股票所在的生物技术行业中，整体涨幅为1.00%。Anavex Life Sciences Corp.公司简介：Anavex Life Sciences Corp 是一家临床阶段的生物制药公司，致力于通过精准医疗开发针对中枢神经系统疾病的差异化治疗药物，这些疾病存在高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702233534a72aea6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702233534a72aea6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVXL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anavex.com","stockEarnings":[{"period":"1week","weight":-0.0871},{"period":"1month","weight":0.0194},{"period":"3month","weight":-0.5662},{"period":"6month","weight":-0.5963},{"period":"1year","weight":-0.5667},{"period":"ytd","weight":-0.6583}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anavex Life Sciences Corp.成立于2004年1月23日，位于内华达州。是一家临床阶段的生物制药公司，致力于开发差异化疗法，将精准医学应用于高度未满足需求的中枢神经系统（CNS）疾病。该公司的重点是开发针对阿尔茨海默病、帕金森病、精神分裂症、神经发育、神经退行性疾病、包括雷特综合征在内的罕见疾病以及其他中枢神经系统（CNS）疾病的创新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.045456},{"month":2,"riseRate":0.5,"avgChangeRate":0.134476},{"month":3,"riseRate":0.6,"avgChangeRate":0.076429},{"month":4,"riseRate":0.3,"avgChangeRate":-0.072663},{"month":5,"riseRate":0.7,"avgChangeRate":0.033993},{"month":6,"riseRate":0.7,"avgChangeRate":0.16895},{"month":7,"riseRate":0.5,"avgChangeRate":-0.029973},{"month":8,"riseRate":0.4,"avgChangeRate":-0.036754},{"month":9,"riseRate":0.5,"avgChangeRate":0.010424},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003565},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.028939},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.023298}],"exchange":"NASDAQ","name":"Anavex Life Sciences Corp.","nameEN":"Anavex Life Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anavex Life Sciences Corp.,AVXL,Anavex Life Sciences Corp.股票,Anavex Life Sciences Corp.股票老虎,Anavex Life Sciences Corp.股票老虎国际,Anavex Life Sciences Corp.行情,Anavex Life Sciences Corp.股票行情,Anavex Life Sciences Corp.股价,Anavex Life Sciences Corp.股市,Anavex Life Sciences Corp.股票价格,Anavex Life Sciences Corp.股票交易,Anavex Life Sciences Corp.股票购买,Anavex Life Sciences Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anavex Life Sciences Corp.(AVXL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anavex Life Sciences Corp.(AVXL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}